Medications for Induced Hypotension
Other names: Controlled Hypotension; Deliberate Induced Hypotension; Perioperative Hemodynamic Control,
Induced hypotension is when the blood pressure is intentionally lowered during surgery to decrease the amount of blood loss and therefore reduce the need for blood transfusions. Reducing the blood pressure also results in less blood in the surgical field, giving a clearer surgical view.
For induced hypotension the systolic blood pressure is reduced to between 80 and 90 mm Hg, or mean arterial pressure is reduced to 50-65 mm Hg in patients with normal blood pressure or a reduction 30% below the baseline mean arterial pressure in other patients.
Blood pressure is reduced by decreasing cardiac output, and/or reducing blood pressure. This can be achieved by controlling venous return by positioning the patient or by use of medications for example inhaled anesthetics or vasodilating drugs.
Complications of induced hypotension are related to the decrease in blood flow and can include insufficient blood flow to the brain, delayed awakening, blood clot within the brain, permanent brain damage and death.
Drugs used to treat Induced Hypotension
The following list of medications are in some way related to, or used in the treatment of this condition.
|Drug name||Rating||Reviews||Activity ?||Rx/OTC||Pregnancy||CSA||Alcohol|
Generic name: nitroprusside systemic
|Rating||For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|
|Activity||Activity is based on recent site visitor activity relative to other medications in the list.|
|OTC||Over the Counter.|
|Rx/OTC||Prescription or Over the Counter.|
|Off-label||This medication may not be approved by the FDA for the treatment of this condition.|
|EUA||An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.|
|A||Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).|
|B||Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.|
|C||Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.|
|D||There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.|
|X||Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.|
|N||FDA has not classified the drug.|
|Controlled Substances Act (CSA) Schedule|
|M||The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.|
|U||CSA Schedule is unknown.|
|N||Is not subject to the Controlled Substances Act.|
|1||Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.|
|2||Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.|
|3||Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.|
|4||Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.|
|5||Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.|
|X||Interacts with Alcohol.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.